Dominic Piscitelli
CIK: 0001695028
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Oric Pharmaceuticals, Inc.
Discretionary Trading P&L
Holdings
Transaction History (32 total)
- Oct 20, 2026ORIC
Oric Pharmaceuticals, Inc.
Sale(S)Direct14K shares at avg. $13.53$189K - Oct 20, 2026ORIC
Oric Pharmaceuticals, Inc.
Exercise(M)Direct14K shares at avg. $4.36$61K - Sep 28, 2026ORIC
Oric Pharmaceuticals, Inc.
Exercise(M)Direct13.4K shares at avg. $4.36$58K - Sep 28, 2026ORIC
Oric Pharmaceuticals, Inc.
Sale(S)Direct13.4K shares at avg. $13.53$181K - Sep 24, 2026ORIC
Oric Pharmaceuticals, Inc.
Sale(S)Direct100 shares at avg. $13.50$1K - Sep 24, 2026ORIC
Oric Pharmaceuticals, Inc.
Sale(S)Direct500 shares at avg. $13.51$7K - Sep 24, 2026ORIC
Oric Pharmaceuticals, Inc.
Exercise(M)Direct600 shares at avg. $4.36$3K - Aug 26, 2026ORIC
Oric Pharmaceuticals, Inc.
Exercise(M)Direct25K shares at avg. $6.00$150K - Aug 26, 2026ORIC
Oric Pharmaceuticals, Inc.
Exercise(M)Direct52K shares at avg. $4.36$227K - Aug 26, 2026ORIC
Oric Pharmaceuticals, Inc.
Sale(S)Direct77K shares at avg. $13.69$1.1M - Feb 24, 2026ORIC
Oric Pharmaceuticals, Inc.
Sale(S)Direct52K shares at avg. $13.51$703K - Feb 24, 2026ORIC
Oric Pharmaceuticals, Inc.
Exercise(M)Direct52K shares at avg. $4.36$227K - Jan 2, 2026ORIC
Oric Pharmaceuticals, Inc.
Award(A)DirectRestricted Stock Unit
34.5K shares- - Jan 2, 2026ORIC
Oric Pharmaceuticals, Inc.
Award(A)DirectStock Option (right to buy)
206.5K shares- - Dec 16, 2025ORIC
Oric Pharmaceuticals, Inc.
Sale(S)Direct10.7K shares at avg. $9.06$97K - Dec 15, 2025ORIC
Oric Pharmaceuticals, Inc.
Exercise(M)Direct29.3K shares- - Oct 6, 2025ORIC
Oric Pharmaceuticals, Inc.
Exercise(M)Direct11K shares at avg. $4.36$48K - Oct 6, 2025ORIC
Oric Pharmaceuticals, Inc.
Sale(S)Direct11K shares at avg. $14.52$160K - Jul 1, 2025ORIC
Oric Pharmaceuticals, Inc.
Sale(S)Direct20K shares at avg. $10.05$201K - Jun 24, 2025ORIC
Oric Pharmaceuticals, Inc.
Sale(S)Direct32.5K shares at avg. $10.50$341K - Jun 23, 2025ORIC
Oric Pharmaceuticals, Inc.
Sale(S)Direct450 shares at avg. $10.01$5K - Jun 23, 2025ORIC
Oric Pharmaceuticals, Inc.
Sale(S)Direct584 shares at avg. $10.00$6K - Jun 12, 2025ORIC
Oric Pharmaceuticals, Inc.
Sale(S)Direct300 shares at avg. $10.00$3K - Jun 11, 2025ORIC
Oric Pharmaceuticals, Inc.
Sale(S)Direct1.7K shares at avg. $10.01$17K - Jun 11, 2025ORIC
Oric Pharmaceuticals, Inc.
Sale(S)Direct1.3K shares at avg. $10.00$13K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Oct 20, 2026 | ORIC Oric Pharmaceuticals, Inc. | Sale(S) | 14,000 | $13.53 | $189,391 | Direct |
| Oct 20, 2026 | ORIC Oric Pharmaceuticals, Inc. | Exercise(M) | 14,000 | $4.36 | $61,040 | Direct |
| Sep 28, 2026 | ORIC Oric Pharmaceuticals, Inc. | Exercise(M) | 13,400 | $4.36 | $58,424 | Direct |
| Sep 28, 2026 | ORIC Oric Pharmaceuticals, Inc. | Sale(S) | 13,400 | $13.53 | $181,258 | Direct |
| Sep 24, 2026 | ORIC Oric Pharmaceuticals, Inc. | Sale(S) | 100 | $13.50 | $1,350 | Direct |
| Sep 24, 2026 | ORIC Oric Pharmaceuticals, Inc. | Sale(S) | 500 | $13.51 | $6,753 | Direct |
| Sep 24, 2026 | ORIC Oric Pharmaceuticals, Inc. | Exercise(M) | 600 | $4.36 | $2,616 | Direct |
| Aug 26, 2026 | ORIC Oric Pharmaceuticals, Inc. | Exercise(M) | 25,000 | $6.00 | $150,000 | Direct |
| Aug 26, 2026 | ORIC Oric Pharmaceuticals, Inc. | Exercise(M) | 52,000 | $4.36 | $226,720 | Direct |
| Aug 26, 2026 | ORIC Oric Pharmaceuticals, Inc. | Sale(S) | 77,000 | $13.69 | $1,053,814 | Direct |
| Feb 24, 2026 | ORIC Oric Pharmaceuticals, Inc. | Sale(S) | 52,000 | $13.51 | $702,686 | Direct |
| Feb 24, 2026 | ORIC Oric Pharmaceuticals, Inc. | Exercise(M) | 52,000 | $4.36 | $226,720 | Direct |
| Jan 2, 2026 | ORIC Oric Pharmaceuticals, Inc. | Award(A) Restricted Stock Unit | 34,500 | - | - | Direct |
| Jan 2, 2026 | ORIC Oric Pharmaceuticals, Inc. | Award(A) Stock Option (right to buy) | 206,500 | - | - | Direct |
| Dec 16, 2025 | ORIC Oric Pharmaceuticals, Inc. | Sale(S) | 10,720 | $9.06 | $97,127 | Direct |
| Dec 15, 2025 | ORIC Oric Pharmaceuticals, Inc. | Exercise(M) | 29,333 | - | - | Direct |
| Oct 6, 2025 | ORIC Oric Pharmaceuticals, Inc. | Exercise(M) | 11,000 | $4.36 | $47,960 | Direct |
| Oct 6, 2025 | ORIC Oric Pharmaceuticals, Inc. | Sale(S) | 11,000 | $14.52 | $159,719 | Direct |
| Jul 1, 2025 | ORIC Oric Pharmaceuticals, Inc. | Sale(S) | 20,000 | $10.05 | $200,972 | Direct |
| Jun 24, 2025 | ORIC Oric Pharmaceuticals, Inc. | Sale(S) | 32,466 | $10.50 | $341,039 | Direct |
| Jun 23, 2025 | ORIC Oric Pharmaceuticals, Inc. | Sale(S) | 450 | $10.01 | $4,505 | Direct |
| Jun 23, 2025 | ORIC Oric Pharmaceuticals, Inc. | Sale(S) | 584 | $10.00 | $5,840 | Direct |
| Jun 12, 2025 | ORIC Oric Pharmaceuticals, Inc. | Sale(S) | 300 | $10.00 | $3,000 | Direct |
| Jun 11, 2025 | ORIC Oric Pharmaceuticals, Inc. | Sale(S) | 1,700 | $10.01 | $17,017 | Direct |
| Jun 11, 2025 | ORIC Oric Pharmaceuticals, Inc. | Sale(S) | 1,276 | $10.00 | $12,760 | Direct |
1-25 of 32 transactions
About Piscitelli Dominic
Piscitelli Dominic (SEC CIK 0001695028) files insider reports with the SEC as Chief Financial Officer of Oric Pharmaceuticals, Inc. (ORIC).
Signal8 holds 15 ownership filings by Piscitelli Dominic, all Form 4s, filed between Dec 17, 2024 and Oct 21, 2026. Those filings report 32 transactions, from Dec 15, 2024 to Oct 20, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Piscitelli Dominic's filings is in SOUTH SAN FRANCISCO, CA.
Recent filings by Piscitelli Dominic
- Oct 20, 2026: Open-market sale of ORIC shares (Form 4, code S).
- Oct 20, 2026: Option exercise of ORIC shares (Form 4, code M).
- Sep 28, 2026: Option exercise of ORIC shares (Form 4, code M).
- Sep 28, 2026: Open-market sale of ORIC shares (Form 4, code S).
- Sep 24, 2026: Open-market sales of ORIC shares (2 lines, Form 4, code S).
Other insiders filing for Oric Pharmaceuticals, Inc. (ORIC)
- Heyman Richard A., Director
- You Angie, Director
- Kunkel Lori Anne, Director
- Hoerter Steven L., Director
- Dier Mardi, Director
- Multani Pratik S, Chief Medical Officer